Skip to main content
Caplight Logo









Esperance Pharmaceuticals, Inc.

Esperance Pharmaceuticals, Inc.

Private
Houston, TexasHealthcare & Life Scienceshttps://esperancepharma.com

Company Overview

Esperance Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. It was founded in 2006.

Esperance Pharmaceuticals, Inc. is a biotechnology company that develops targeted anti-cancer drugs using its proprietary cationic lytic peptide (CLYP) technology platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Esperance Pharmaceuticals, Inc. Comparables

Compare Esperance Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.

Esperance Pharmaceuticals, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
A28 Therapeutics
88%
Cybrexa Therapeutics
79%
Oncolyze, Inc.
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Esperance Pharmaceuticals, Inc. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Esperance Pharmaceuticals, Inc.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Esperance Pharmaceuticals, Inc. Filings

Explore SEC and related filing metadata, where available.

Esperance Pharmaceuticals, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Esperance Pharmaceuticals, Inc.'s valuation, stock price, and market status.

Is Esperance Pharmaceuticals, Inc. a public or private company?

Esperance Pharmaceuticals, Inc. is a private company.

What is the current stock price of Esperance Pharmaceuticals, Inc.?

Esperance Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Esperance Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Esperance Pharmaceuticals, Inc. worth (valuation)?

Valuation information for Esperance Pharmaceuticals, Inc. is not publicly available.

Can I buy Esperance Pharmaceuticals, Inc. stock?

Esperance Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Esperance Pharmaceuticals, Inc.'s last funding round?

Funding round information for Esperance Pharmaceuticals, Inc. is not publicly available.

Who are the main investors in Esperance Pharmaceuticals, Inc.?

Investor information for Esperance Pharmaceuticals, Inc. is not publicly disclosed.

Will Esperance Pharmaceuticals, Inc. IPO soon?

No public IPO plans have been announced for Esperance Pharmaceuticals, Inc..

How can I track Esperance Pharmaceuticals, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Esperance Pharmaceuticals, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersHouston, Texas
Year Founded2006
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?